These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12491932)

  • 21. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD; Sayed R; Garg M; Patil VA
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation screening of Charcot-Marie-Tooth patients in Poland.
    Kochański A; Timmerman V; Jedrzejowska H; Ryniewicz B; Löfgren A; De Vriendt E; Van Broeckhoven C; Latos-Bieleńska A; Hausmanowa-Petrusewicz I
    Ann N Y Acad Sci; 1999 Sep; 883():493-6. PubMed ID: 10586282
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultraviolet cross-linking assay to measure sequence-specific DNA binding in vivo.
    Biggin MD
    Methods Enzymol; 1999; 304():496-515. PubMed ID: 10372378
    [No Abstract]   [Full Text] [Related]  

  • 25. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of monogenic diseases of the peripheral nervous system].
    Haupt A; Epplen JT
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1469-72. PubMed ID: 8983897
    [No Abstract]   [Full Text] [Related]  

  • 27. A "nerve" ending story in the identification of mutations in Charcot-Marie-Tooth neuropathy.
    Timmerman V; Herrmann DN
    Neurology; 2006 Oct; 67(7):1114-5. PubMed ID: 17030741
    [No Abstract]   [Full Text] [Related]  

  • 28. [Charcot-Marie-Tooth disorders with autosomal recessive inheritance. Search for the molecular diagnostics model].
    Kabzińska D; Franaszczyk M; Kochański A
    Med Wieku Rozwoj; 2009; 13(2):146-53. PubMed ID: 19837996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the PMP-22 gene region (17p11.2-12) are crucial for simplified diagnosis of duplications/deletions.
    Haupt A; Schöls L; Przuntek H; Epplen JT
    Hum Genet; 1997 May; 99(5):688-91. PubMed ID: 9150743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A.
    Young P; Stögbauer F; Wiebusch H; Löfgren A; Timmerman V; Van Broeckhoven C; Ringelstein EB; Assmann G; Funke H
    Neurology; 1998 Mar; 50(3):760-3. PubMed ID: 9521270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restriction enzyme digestion, gel electrophoresis, and vacuum blotting of DNA to nylon membranes.
    Stacey J; Isaac PG
    Methods Mol Biol; 1994; 28():25-36. PubMed ID: 8118515
    [No Abstract]   [Full Text] [Related]  

  • 34. A new gene for the Charcot-Marie-Tooth disorder.
    Ben-Asher E; Lancet D
    Isr Med Assoc J; 2004 Jun; 6(6):376-7. PubMed ID: 15214472
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease.
    Maeda MH; Mitsui J; Soong BW; Takahashi Y; Ishiura H; Hayashi S; Shirota Y; Ichikawa Y; Matsumoto H; Arai M; Okamoto T; Miyama S; Shimizu J; Inazawa J; Goto J; Tsuji S
    Ann Neurol; 2012 Jan; 71(1):84-92. PubMed ID: 22275255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing DNA structure with psoralen in vitro.
    Ussery DW; Hoepfner RW; Sinden RR
    Methods Enzymol; 1992; 212():242-62. PubMed ID: 1325599
    [No Abstract]   [Full Text] [Related]  

  • 38. Charcot-Marie-Tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity.
    Lupski JR
    Pediatr Res; 1999 Feb; 45(2):159-65. PubMed ID: 10022584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
    Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
    Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.